TrialTheScientificWorldJournal2012

Botulinum neurotoxin type A for the treatment of benign prostatic hyperplasia: randomized study comparing two doses.

René Arnouk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.